About Elbrit Life Sciences
Elbrit Life Sciences is a company based in Mumbai (India) founded in 2014. It operates as a B2B. The company has 213 employees as of March 31, 2023. Elbrit Life Sciences offers products and services including Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications. Elbrit Life Sciences operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Mumbai, India
- Employees 213 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elbrit Life Sciences Private Limited
- Date of Incorporation 18 Jan, 2014
- Jurisdiction Erode, Tamil Nadu, India
-
Annual Revenue
$3.61 M (USD)65.6as on Mar 31, 2023
-
Net Profit
$44.9 K (USD)72.82as on Mar 31, 2023
-
EBITDA
$271.08 K (USD)69.49as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
213
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elbrit Life Sciences
Elbrit Life Sciences offers a comprehensive portfolio of products and services, including Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications.
Treats heart-related conditions through innovative drug formulations.
Manages blood sugar levels with advanced pharmaceutical solutions.
Addresses digestive disorders using research-based treatments.
Alleviates nerve damage symptoms with effective drug options.
Supports mental health conditions through targeted therapies.
Funding Insights of Elbrit Life Sciences
Detailed funding history for Elbrit Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elbrit Life Sciences
Investment portfolio details for Elbrit Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elbrit Life Sciences
Detailed financials for Elbrit Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elbrit Life Sciences Comparisons
Peer comparison for Elbrit Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elbrit Life Sciences
Elbrit Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Elbrit Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elbrit Life Sciences
Complete news archive for Elbrit Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elbrit Life Sciences
Elbrit Life Sciences was founded in 2014.
Elbrit Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2023, the latest employee count at Elbrit Life Sciences is 213.
Annual revenue of Elbrit Life Sciences is $3.61M as on Mar 31, 2023.
Elbrit Life Sciences is a pharmaceutical company based in India that focuses on developing and manufacturing medications for therapies like cardiovascular and diabetes. They emphasize innovation, research, and partnerships with healthcare providers to deliver quality products. With offices in Mumbai, Chennai, and Bengaluru, they distribute cutting-edge treatments and aim for global expansion while prioritizing patient wellbeing and environmental responsibility.
Elbrit Life Sciences's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Elbrit Life Sciences offers Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications.